We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current KBYPF market cap is 2.85B. The company's latest EPS is JPY 267.5563 and P/E is 0.14.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 168.05B | 150.51B | 155.25B | 166.26B | 173.46B |
| Operating Income | 24.7B | 24.82B | 25.76B | 26.6B | 25.72B |
| Net Income | 19.14B | 19.21B | 19.72B | 20.02B | 20.34B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 233.4B | 238.37B | 252.55B | 255.83B | 267.47B |
| Total Liabilities | 60.74B | 55.78B | 56.95B | 57.93B | 62.66B |
| Total Equity | 172.66B | 182.58B | 195.6B | 197.9B | 204.82B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 20.09B | 23.99B | 22.42B | 31.91B | 18.36B |
| Investing | -5.07B | -12.66B | 7.99B | -14.31B | -19.58B |
| Financing | -14.58B | -6.02B | -10.38B | -20.76B | -19.46B |
| Market Cap | 2.85B |
| Price to Earnings Ratio | 0.14 |
| Price to Sales Ratio | 0.02 |
| Price to Cash Ratio | 0.04 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 76.01M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -3.85% |
| 52 Week High | 38.93 |
| 52 Week Low | 31.81 |
| Spread (Intraday) | 3.8 (9.62%) |
| Company Name | Kobayashi Pharmaceutical Company Ltd (PK) |
| Address |
4-4-10 doshomachi higashiosaka, osaka 541-0045 |
| Website | https://www.kobayashi.co.jp |
| Industry | household durable & appliances (C12) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
